Gilder Gagnon Howe & CO LLC Gilead Sciences, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $1.07 Million - $1.34 Million	-17,199 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $761,740 - $884,520	-10,530 Reduced 37.97%	17,199 $1.32 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $1.74 Million - $2.22 Million	27,729 New	27,729 $2.07 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.